Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP681323.RAkeklhfRNaj873Bq6z-v-zkBIf9fWlbvN31MFFeweegs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP681323.RAkeklhfRNaj873Bq6z-v-zkBIf9fWlbvN31MFFeweegs130_assertion type Assertion NP681323.RAkeklhfRNaj873Bq6z-v-zkBIf9fWlbvN31MFFeweegs130_head.
- NP681323.RAkeklhfRNaj873Bq6z-v-zkBIf9fWlbvN31MFFeweegs130_assertion description "[The absence of prior treatment with immunotherapy, the total dose of IL-2 administered, and the maximal rebound lymphocytosis after cessation of IL-2 correlated with achieving a complete response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681323.RAkeklhfRNaj873Bq6z-v-zkBIf9fWlbvN31MFFeweegs130_provenance.
- NP681323.RAkeklhfRNaj873Bq6z-v-zkBIf9fWlbvN31MFFeweegs130_assertion evidence source_evidence_literature NP681323.RAkeklhfRNaj873Bq6z-v-zkBIf9fWlbvN31MFFeweegs130_provenance.
- NP681323.RAkeklhfRNaj873Bq6z-v-zkBIf9fWlbvN31MFFeweegs130_assertion SIO_000772 9742914 NP681323.RAkeklhfRNaj873Bq6z-v-zkBIf9fWlbvN31MFFeweegs130_provenance.
- NP681323.RAkeklhfRNaj873Bq6z-v-zkBIf9fWlbvN31MFFeweegs130_assertion wasDerivedFrom befree-20140225 NP681323.RAkeklhfRNaj873Bq6z-v-zkBIf9fWlbvN31MFFeweegs130_provenance.
- NP681323.RAkeklhfRNaj873Bq6z-v-zkBIf9fWlbvN31MFFeweegs130_assertion wasGeneratedBy ECO_0000203 NP681323.RAkeklhfRNaj873Bq6z-v-zkBIf9fWlbvN31MFFeweegs130_provenance.